EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION
批准号:
8173212
负责人:
Larry S. Sherman
金额:
$7.61万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30
关键词:
AdultApoptosisAxonBloodBlood VesselsCD44 AntigensCD44 geneCell MaturationCellsComputer Retrieval of Information on Scientific Projects DatabaseDataEncephalomyelitisExperimental Autoimmune EncephalomyelitisFundingGlycoproteinsGrantHomingHyaluronanInflammatoryInjection of therapeutic agentInstitutionLesionMediator of activation proteinMolecular WeightMusOligodendrogliaProductionResearchResearch PersonnelResourcesSourceStem cellsT-LymphocyteTestingUndifferentiatedUnited States National Institutes of Healthcytokinedysmyelinationnerve stem cell
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Systemic injection of adult neural stem cells (aNSCs) into mice with experimental autoimmune encephalomyelitis (EAE) can provide a source of new oligodendrocytes that can remyelinate demyelinated or dysmyelinated axons. However, systemically-injected aNSCs often fail to differentiate and remain undifferentiated in peri-vascular domains of demyelinated lesions where they promote apoptosis of blood-born CNS-infiltrating encephalitogenic T cells. We discovered that a high molecular weight form of hyaluronan (HA), accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor cell maturation. The major receptor for HA is the CD44 transmembrane glycoprotein. Our preliminary data suggest that HA and CD44 regulate functions relevant to how aNSCs behave in demyelinated lesions, including NSC differentiation and production of pro-inflammatory cytokines. We propose that CD44 and HA are critical mediators of aNSC recruitment to demyelinated lesions and that HA, at least, can regulate whether NSCs differentiate into myelinating cells or fail to differentiate and promote T cell apoptosis at perivascular domains where HA accumulates. In this study, we aim to test the hypotheses: (1) That high molecular weight HA inhibits aNSC differentiation; (2) That NSC homing to EAE lesions depends on interactions between CD44 and HA; and (3) That HA regulates the immunomodulatory activities of NSC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyaluron as a regulator of chemotherapy-induced changes in neurogenesis
-
批准号:10346925
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2021
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY
-
批准号:8357753
-
项目类别:
-
资助金额:$4.36万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
COLLABORATIVE MS RESEARCH CENTER AWARD
-
批准号:8357887
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
EFFECTS OF HYALURONAN ON NEURAL STEM CELL HOMING AND DIFFERENTIATION
-
批准号:8357755
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
EVALUTATION OF HUMAN STEM CELL ENGRAFTMENT TO SHIVERER MICE
-
批准号:8357890
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF HYALURONAN INHIBITORS IN ETHANOL-INDUCED CHANGES IN NEUROGENESIS
-
批准号:8357886
-
项目类别:
-
资助金额:$1.82万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
THERAPEUTIC REMYELINATION STRATEGIES IN A NOVEL MODEL OF MS
-
批准号:8357821
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
TARGETING NEUROTROPHIC FACTOR RECEPTORS TO BLOCK PAIN IN SCHWANNOMATOSIS
-
批准号:8357885
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
WHITE MATTER DAMAGE IN AGE-RELATED COGNITIVE DECLINE
-
批准号:8357822
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
EFFECTS OF ETHANOL EXPOSURE ON HYALURONAN-MEDIATED ADULT NEUROGENESIS
-
批准号:8357865
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
NOVEL HYALURONIDASE INHIBITORS FOR THE PROMOTION OF REMYELINATION
-
批准号:8357867
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF EXTRACELLULAR MATRIX IN HYPOXIC-ISCHEMIC PERINATAL WHITE MATTER INJURY
-
批准号:8173210
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF SNF5 IN SCHWANN CELL TUMORIGENENSIS
-
批准号:8173279
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
VASCULAR ENDOTHELIUM-DERIVED FACTORS IN STURGE-WEBER SYNDROME HYPERMYELINATION
-
批准号:8173278
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
TARGETING HYALURONIDASES AS A STRATEGY TO REVERSE REMYELINATION FAILURE
-
批准号:8173316
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
EVALUATION OF THE SAFETY & EFFICACY OF AN IMPLANTED BIODEGRADABLE SCAFFOLD
-
批准号:8173320
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
THERAPEUTIC REMYELINATION STRATEGIES IN A NOVEL MODEL OF MS
-
批准号:8173318
-
项目类别:
-
资助金额:$9.51万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF SW1/SNF FACTORS IN SCHWANNOMATOSIS ASSOCIATED PAIN
-
批准号:8173317
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
ROLE OF HYALURONAN IN INHIBITION OF REMYELINATION
-
批准号:8173192
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
WHITE MATTER DAMAGE IN AGE-RELATED COGNITIVE DECLINE
-
批准号:8173319
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2010
-
负责人:Larry S. Sherman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: